Kevin G Lafond insider trades: Ziopharm Oncology (ZIOP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kevin reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 8, 2021 | ZIOP | ↓ Sell | 18,020 | $3.09 | $56K | Direct | Jan 12, 2021 (4d) |
| Jan 2, 2020 | ZIOP | ↓ Sell | 21,570 | $4.55 | $98K | Direct | Jan 3, 2020 (1d) |
| Nov 26, 2019 | ZIOP | ↓ Sell | 11,667 | $5.25 | $61K | Direct | Nov 27, 2019 (1d) |
| Jun 3, 2015 | ZIOP | ↓ Sell | 57,500 | $9.65 | $555K | Direct | Jun 5, 2015 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Kevin G Lafond's insider trades
Kevin G Lafond is SVP, Treasurer & CAO at Ziopharm Oncology (ZIOP). Since Jun 3, 2015, Kevin has reported no open-market purchases and 4 sales worth $770K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (9 filings), shares withheld for taxes (5 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ZIOP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.